• KAFM
  • Contact us
  • E-Submission
ABOUT
ARTICLE CATEGORY
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

1
results for

"Mi-Na Kim"

Filter

Article category

Keywords

Publication year

"Mi-Na Kim"

Original Article
Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older
Ah-Leum Ahn, Jae-Kyung Choi, Mi-Na Kim, Seun-Ah Kim, Eun-Jung Oh, Hyuk-Jung Kweon, Dong-Yung Cho
Korean J Fam Med 2013;34(3):199-205.   Published online May 24, 2013
DOI: https://doi.org/10.4082/kjfm.2013.34.3.199
Background

Non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) share common pathogenic mechanisms and many risk factors, and both are linked to an increased risk of cardiovascular diseases. The aim of this study was to assess the association between NAFLD and CKD according to the presence of hypertension and diabetes mellitus in Koreans aged 50 years or older.

Methods

A cross-sectional study of 1,706 subjects who received their routine health examination was conducted between May 2008 and April 2010 at Konkuk University medical center. Biochemical tests for liver and abdominal ultrasonography were performed. CKD was defined as either proteinuria or glomerular filtration rate ≤60 mL/min per 1.73 m2.

Results

Among the 1,706 subjects, There were 545 (31.9%) with non-alcoholic fatty liver disease and 424 (24.9%) with chronic kidney disease. In univariate logistic regression analysis, NAFLD was significantly associated with CKD (odds ratio [OR], 1.69; 95% confidence interval [CI], 1.34 to 2.12). In multivariate logistic regression analysis adjusted for age, sex, current smoking, abdominal obesity, aspartate aminotransferases, alanine aminotransferases, γ-glutamyltransferase, hypertension, diabetes mellitus, hypertriglyceridemia, and low high-density lipoprotein cholesterol, NAFLD was associated with CKD (adjusted OR, 1.68; 95% CI, 1.27 to 2.24). This relationship remained significant after classification according to the presence of hypertension or diabetes mellitus.

Conclusion

NAFLD diagnosed by ultrasonography was significantly associated with CKD in Koreans aged 50 years or older.

Citations

Citations to this article as recorded by  
  • The association between steatotic liver disease and chronic kidney disease: a meta-analysis and Mendelian randomization study highlighting metabolic comorbidities
    Xiang Ji, Jinguo Jiang, Yunyun Liu, Liuxin Li, Honghao Yang, Zheng Ma, Chenying Wang, Tingjing Zhang, Yuhong Zhao, Yashu Liu, Yang Xia
    Nutrition & Diabetes.2026;[Epub]     CrossRef
  • Global Prevalence, Incidence, and Outcomes of Coexisting MASLD and Chronic Kidney Disease: A Meta‐Analysis
    Martin T. W. Kueh, Jacob Kang Wen Yeo, Yiming Chen, Nicole Ying Zi Chua, Hui Lian Koh, Seng Pei Khaw, Hassan Jabbar, Jiong‐Wei Wang, Kwan Lee, Yip Han Chin, Dan Qin Sun, Alessandro Mantovani, Giovanni Targher, Nicholas W. S. Chew, Xiao‐Dong Zhou, Ming‐Hua
    Liver International.2026;[Epub]     CrossRef
  • Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis
    Marc Gurun, Paul Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F. Dillon, Christopher J. Byrne, Anna Di Sessa
    PLOS ONE.2024; 19(4): e0299507.     CrossRef
  • Impact of Kiwifruit Consumption on Cholesterol Metabolism in Rat Liver: A Gene Expression Analysis in Induced Hypercholesterolemia
    Abdolvahab Ebrahimpour Gorji, Anna Ciecierska, Hanna Leontowicz, Zahra Roudbari, Tomasz Sadkowski
    Nutrients.2024; 16(23): 3999.     CrossRef
  • Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross Talk
    Jacob Nysather, Eda Kaya, Paul Manka, Prakash Gudsoorkar, Wing-Kin Syn
    Advances in Kidney Disease and Health.2023; 30(4): 315.     CrossRef
  • Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease
    Ziwen Tao, Yueyue Li, Baoquan Cheng, Tao Zhou, Yanjing Gao
    Journal of Clinical and Translational Hepatology.2022; 10(1): 164.     CrossRef
  • Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease
    Chan-Young Jung, Geun Woo Ryu, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
    Diabetologia.2022; 65(3): 518.     CrossRef
  • Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease
    Mehmet Kanbay, Mustafa C. Bulbul, Sidar Copur, Baris Afsar, Alan A. Sag, Dimitrie Siriopol, Masanari Kuwabara, Silvia Badarau, Adrian Covic, Alberto Ortiz
    Journal of Nephrology.2021; 34(3): 649.     CrossRef
  • Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study
    Ana J. F. C. Aguiar, Jaluza L. C. de Queiroz, Pedro P. A. Santos, Christina S. Camillo, Alexandre C. Serquiz, Izael S. Costa, Gerciane S. Oliveira, Ana F. T. Gomes, Lídia L. R. Matias, Rafael O. A. Costa, Thaís S. Passos, Ana H. A. Morais
    International Journal of Molecular Sciences.2021; 22(18): 9968.     CrossRef
  • Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
    Stefania Kiapidou, Christina Liava, Maria Kalogirou, Evangelos Akriviadis, Emmanouil Sinakos
    Annals of Hepatology.2020; 19(2): 134.     CrossRef
  • Association of nonalcoholic fatty liver and chronic kidney disease: An analysis of 37,825 cases from health checkup center in Taiwan
    Hao-Wen Liu, Jia-Sin Liu, Ko-Lin Kuo
    Tzu Chi Medical Journal.2020; 32(1): 65.     CrossRef
  • NAFLD as a driver of chronic kidney disease
    Christopher D. Byrne, Giovanni Targher
    Journal of Hepatology.2020; 72(4): 785.     CrossRef
  • Correlation Between Non-Alcoholic Fatty Liver and Chronic Kidney Disease
    Hasyim Kasim, St. Rabiul Zatalia, Haerani Rasyid, Syakib Bakri, Muhammad L. Parewangi, Fardah Akil, Arifin Seweng
    The Open Urology & Nephrology Journal.2020; 13(1): 1.     CrossRef
  • Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
    Andrew A. Li, Aijaz Ahmed, Donghee Kim
    Gut and Liver.2020; 14(2): 168.     CrossRef
  • Risk of Kidney Dysfunction IN Nafld
    Alessandro Mantovani, Chiara Zusi, Andrea Dalbeni, Giorgio Grani, Elena Buzzetti
    Current Pharmaceutical Design.2020; 26(10): 1045.     CrossRef
  • Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease
    Rajkumar Chinnadurai, James Ritchie, Darren Green, Philip A Kalra
    Nephrology Dialysis Transplantation.2019; 34(3): 449.     CrossRef
  • Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis
    Robert M. Wilechansky, Alison Pedley, Joseph M. Massaro, Udo Hoffmann, Emelia J. Benjamin, Michelle T. Long
    Liver International.2019; 39(8): 1535.     CrossRef
  • Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity‐matched cohort study
    Haesuk Park, Ghadeer K. Dawwas, Xinyue Liu, Mindie H. Nguyen
    Journal of Internal Medicine.2019; 286(6): 711.     CrossRef
  • Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
    Leon A Adams, Quentin M Anstee, Herbert Tilg, Giovanni Targher
    Gut.2017; 66(6): 1138.     CrossRef
  • Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
    Giovanni Targher, Christopher D. Byrne
    Nature Reviews Nephrology.2017; 13(5): 297.     CrossRef
  • Nonalcoholic fatty liver disease - A multisystem disease?
    Ivana Mikolasevic, Sandra Milic, Tamara Turk Wensveen, Ivana Grgic, Ivan Jakopcic, Davor Stimac, Felix Wensveen, Lidija Orlic
    World Journal of Gastroenterology.2016; 22(43): 9488.     CrossRef
  • NAFLD: A multisystem disease
    Christopher D. Byrne, Giovanni Targher
    Journal of Hepatology.2015; 62(1): S47.     CrossRef
  • Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes
    Yongqiang Li, Shuangshuang Zhu, Bin Li, Xiaofei Shao, Xinyu Liu, Aiqun Liu, Bifang Wu, Ying Zhang, Honglei Wang, Xiaohong Wang, Kangping Deng, Qin Liu, Min Huang, Hongmei Liu, Harry Holthöfer, Hequn Zou
    International Urology and Nephrology.2014; 46(9): 1785.     CrossRef
  • Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension
    Ki-Chul Sung, Sarah H. Wild, Christopher D. Byrne
    Journal of Hepatology.2014; 60(5): 1040.     CrossRef
  • Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
    Giovanni Musso, Roberto Gambino, James H. Tabibian, Mattias Ekstedt, Stergios Kechagias, Masahide Hamaguchi, Rolf Hultcrantz, Hannes Hagström, Seung Kew Yoon, Phunchai Charatcharoenwitthaya, Jacob George, Francisco Barrera, Svanhildur Hafliðadóttir, Einar
    PLoS Medicine.2014; 11(7): e1001680.     CrossRef
  • CKD and Nonalcoholic Fatty Liver Disease
    Giovanni Targher, Michel B. Chonchol, Christopher D. Byrne
    American Journal of Kidney Diseases.2014; 64(4): 638.     CrossRef
  • 6,850 View
  • 43 Download
  • 26 Crossref
TOP